Cornelius Engelmann(@CorneliusEngel7) 's Twitter Profileg
Cornelius Engelmann

@CorneliusEngel7

Research on liver disease and cirrhosis, at Charité Berlin

ID:1348717067319574528

calendar_today11-01-2021 19:43:22

69 Tweets

159 Followers

135 Following

Cornelius Engelmann(@CorneliusEngel7) 's Twitter Profile Photo

Prof Rajiv Jalan: very glad to present the new Visiting Professor at Charité. Time to strengthen research translation and innovation.

Prof Rajiv Jalan: very glad to present the new Visiting Professor at Charité. Time to strengthen research translation and innovation.
account_circle
A-TANGO(@ATANGO_H2020) 's Twitter Profile Photo

2 years + 4 months into the project, A-TANGO has overcome tremendous challenges & is about to enroll its 1st patient into the G-TAK soon. At today's 5th Steering Committee (SC) Meeting, we realised how far we've come! Prof Rajiv Jalan Cornelius Engelmann Eur. Fdn. for the Study of Chronic Liver Failure

account_circle
MICROB-PREDICT(@MicrobPredict) 's Twitter Profile Photo

Great symposium by experts in the field during last morning’s session of : novelties in the therapeutic landscape for decompensated cirrhosis

✍🏽 Take home message: personalized and stratified treatment for patients with end-stage liver cirrhosis is highly warranted!

Great symposium by experts in the field during last morning’s session of #EASLCongress: novelties in the therapeutic landscape for decompensated cirrhosis ✍🏽 Take home message: personalized and stratified treatment for patients with end-stage liver cirrhosis is highly warranted!
account_circle
A-TANGO(@ATANGO_H2020) 's Twitter Profile Photo

efclif.com/foundation/new…
What's the scientific basis for our new combinatorial treatment of acute-on-chronic liver failure ( )? The by Eur. Fdn. for the Study of Chronic Liver Failure about the recently published study by Cornelius Engelmann et al. (@JHepatology) gives answers! European Liver Patients' Association

efclif.com/foundation/new… What's the scientific basis for our new combinatorial treatment of acute-on-chronic liver failure (#ACLF)? The #PressRelease by @ef_clif about the recently published study by @CorneliusEngel7 et al. (@JHepatology) gives answers! #LiverTwitter @EuropeLiver
account_circle
A-TANGO(@ATANGO_H2020) 's Twitter Profile Photo

Our enterprise 'Fight & ' aka A-TANGO has entered the next phase! During yesterday's Steering Committee (SC) Meeting, we celebrated the successfully completed drug manufacturing process & got ready to initiate the . Eur. Fdn. for the Study of Chronic Liver Failure European Liver Patients' Association EASLnews

Our enterprise 'Fight #LiverFailure & #ACLF' aka A-TANGO has entered the next phase! During yesterday's Steering Committee (SC) Meeting, we celebrated the successfully completed drug manufacturing process & got ready to initiate the #ClinicalTrial. @ef_clif @EuropeLiver @EASLnews
account_circle
Journal of Hepatology(@JHepatology) 's Twitter Profile Photo

Combination of TAK-242 & G-CSF
✅inhibits inflammation
✅promotes hepatic regeneration
✅prevents mortality
➡️in models of

❗️Potential treatment option for

🔓 at👉bit.ly/3zdoT36

Cornelius Engelmann
Prof Rajiv Jalan

Combination of TAK-242 & G-CSF ✅inhibits inflammation ✅promotes hepatic regeneration ✅prevents mortality ➡️in models of #ACuteOnChronicLiverFailure ❗️Potential treatment option for #ACLF 🔓#OpenAccess at👉bit.ly/3zdoT36 @CorneliusEngel7 @RajivJalan1 #LiverTwitter
account_circle
A-TANGO(@ATANGO_H2020) 's Twitter Profile Photo

Save the date - The 4th Steering Committee (SC) Meeting takes place on Tuesday, 29 November 2022, online (via Zoom) from 9 am - 4 pm CET. Check your inbox for details. We are looking forward to seeing you all on-screen🙂! Prof Rajiv Jalan Cornelius Engelmann Daniel Green

Save the date - The 4th Steering Committee (SC) Meeting takes place on Tuesday, 29 November 2022, online (via Zoom) from 9 am - 4 pm CET. Check your inbox for details. We are looking forward to seeing you all on-screen🙂! @RajivJalan1 @CorneliusEngel7 @daneeljunot #ACLF #GTAK
account_circle
Journal of Hepatology(@JHepatology) 's Twitter Profile Photo

Combination of TAK-242 & G-CSF
✅inhibits inflammation
✅promotes hepatic regeneration
✅prevents mortality
➡️in models of

❗️Potential treatment option for

🔓 at👉bit.ly/3zdoT36

Cornelius Engelmann
Prof Rajiv Jalan

Combination of TAK-242 & G-CSF ✅inhibits inflammation ✅promotes hepatic regeneration ✅prevents mortality ➡️in models of #ACuteOnChronicLiverFailure ❗️Potential treatment option for #ACLF 🔓#OpenAccess at👉bit.ly/3zdoT36 @CorneliusEngel7 @RajivJalan1 #LiverTwitter
account_circle
Journal of Hepatology(@JHepatology) 's Twitter Profile Photo

The periportal zone of hepatic lobules
➡️essential role in emergence of -associated

Reprogramming of into a proinflammatory subpopulation
➡️key in endotoxemia-induced

🔓 at👉bit.ly/36nxYul

The periportal zone of hepatic lobules ➡️essential role in emergence of #endotoxemia-associated #liverinjury Reprogramming of #hepatocytes into a proinflammatory subpopulation ➡️key in endotoxemia-induced #immuneresponse 🔓#OpenAccess at👉bit.ly/36nxYul #LiverTwitter
account_circle
Journal of Hepatology(@JHepatology) 's Twitter Profile Photo

🆕Article in press❕

Combination of G-CSF and a inhibitor reduce inflammation and promote regeneration in a mouse model of

Read it here👉bit.ly/3zdoT36

Cornelius Engelmann

🆕Article in press❕ Combination of G-CSF and a #TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of #ACLF Read it here👉bit.ly/3zdoT36 @CorneliusEngel7 #LiverTwitter
account_circle